PLEASANTON, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) will present at the Jefferies
Healthcare Conference in New York, NY, on June 9, 2017. Daniel G. McBride, Esq, Executive Vice President, Chief Operating Officer &
President of CooperVision, Inc., will represent the Company in a presentation scheduled to begin at 10:30 AM ET.
A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at
http://investor.coopercos.com.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is
dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business
units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing
a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is
committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health,
fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has more than 10,000 employees with products sold in over 100
countries. For more information, please visit www.coopercos.com.
COO-G
Source: The Cooper Companies, Inc.
CONTACT: Kim Duncan Vice President, Investor Relations ir@cooperco.com
